| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $656.8M | +14.7% |
| Cost of Revenue | $116.5M | +9.3% |
| R&D Expense | $153.0M | +22.1% |
| SG&A Expense | $92.1M | +4.7% |
| Operating Income | $82.4M | -3.9% |
| Interest Expense | $1.1M | +4.9% |
| Pre-tax Income | $88.8M | -7.4% |
| Income Tax | $32.6M | +33.4% |
| Net Income | $56.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $292.8M | -5.6% |
| Short-term Investments | $17.8M | — |
| Accounts Receivable | $226.2M | +9.3% |
| Current Assets | $559.1M | +4.9% |
| Total Assets | $1.28B | +2.7% |
| Current Liabilities | $103.5M | +23.4% |
| Total Liabilities | $192.8M | +14.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $159.7M | +33.3% |
| Capital Expenditures | $27.1M | +59.6% |
| Investing Cash Flow | -$44.8M | +46.8% |
| Financing Cash Flow | -$129.4M | -2094.9% |
| Free Cash Flow | $132.5M | +29.0% |
| -21.3% |
| EPS (Basic) | $0.33 | -23.3% |
| EPS (Diluted) | $0.32 | -22.0% |
| Stockholders' Equity |
| $1.08B |
| +0.9% |